DSS-induced colitis was exacerbated in myeloid cell-specific MANF knockout mice. Injection of recombinant human MANF (rhMANF, 10 mg·kg–1·d–1, i.v.)from D4 to D6 significantly ameliorated experimental colitis in DSS-treated mice. Here, MANF is linked to colitis.